iBrands Corporation Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune™ in Animal Studies
29 juin 2020 09h00 HE
|
iBrands Corporation
LAS VEGAS, June 29, 2020 (GLOBE NEWSWIRE) -- iBrands Corporation (OTC: IBRC) (“the Company”), a diversified holding and branding company, announces filing of a new patent by nutraceutical product...